SMA Capital Drives Protean Select to Lower Capacity Limit

SMA Capital Drives Protean Select to Lower Capacity Limit

HedgeNordic
HedgeNordicMar 30, 2026

Key Takeaways

  • Capacity cut to SEK 1bn (~$110m) to protect returns
  • SMA mandates share strategy, reducing overall capacity
  • Annualized return 7.7% since inception
  • Total AUM now over $700m across three strategies
  • New subscriptions closed; redemptions stay open

Summary

Protean Select, the long/short equity hedge fund launched in 2022, is cutting its capacity limit from SEK 2 billion (≈$220 million) to SEK 1 billion (≈$110 million) as assets near the new cap. The fund now manages roughly SEK 970 million (≈$107 million) and has halted new subscriptions while keeping redemptions open. The move follows strong inflows via separately managed account (SMA) mandates, which share the same investment universe and effectively reduce overall capacity. Protean Funds’ total AUM across three strategies has just topped $700 million, underscoring its growth despite the tighter limit.

Pulse Analysis

Capacity management has become a strategic lever for boutique hedge funds seeking to preserve alpha. By capping assets, managers can maintain tighter position sizing, reduce market impact, and avoid the performance drag that larger pools often incur. Protean Select’s decision reflects this discipline, aligning its operational bandwidth with a 7.7% annualized return record and a clear hierarchy that places returns above sheer asset growth.

The influx of institutional capital through separately managed accounts (SMAs) adds a layer of complexity. While SMAs allow investors to access the same long/short equity strategy under a customized mandate, they also consume capacity that would otherwise be available for the flagship fund. Protean’s integration of SMA mandates means the combined exposure now approaches the revised SEK 1 billion ceiling, prompting a hard close to new subscriptions. This approach safeguards existing investors from the dilution risk that typically follows unchecked inflows.

For the broader market, Protean’s move may encourage peers to reassess scaling ambitions, especially in niche strategies where agility is paramount. Institutional investors are likely to favor funds that demonstrate proactive capacity controls, viewing them as lower‑risk conduits for steady returns. As more managers adopt similar caps, the industry could see a shift toward a more fragmented but performance‑focused landscape, where capital allocation decisions hinge on process integrity rather than headline AUM growth.

SMA Capital Drives Protean Select to Lower Capacity Limit

Comments

Want to join the conversation?